Histopathological features of ovarian mass among patients attending a tertiary care hospital in South India

Radhika Kasiraj; B. M. Logeswari; P. Banupriya; C. Amirtha; R. Veena

doi:10.18203/2320-1770.ijrcog20241761

Authors

Radhika Kasiraj Department of Obstetrics and Gynaecology, Sree Balaji Medical College and Hospital, Chromepet, Chennai, Tamil Nadu, India
B. M. Logeswari Department of Obstetrics and Gynaecology, Sree Balaji Medical College and Hospital, Chromepet, Chennai, Tamil Nadu, India
P. Banupriya Department of Obstetrics and Gynaecology, Chengelpet Medical College and Hospital, Chengelpet, Tamil Nadu, India
C. Amirtha Department of Obstetrics and Gynaecology, Vinayaka Missions Medical College and Hospital, Vinayaka Mission’s Research Foundation (DU), Karaikal, Puducherry, India
R. Veena Department of Obstetrics and Gynaecology, Prashanth Fertility and Research Centre, Velachery, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20241761

Keywords:

Histopathology, Ovarian mass, Cancer

Abstract

Background: First of all, globally, ovarian tumors are becoming a more common source of morbidity and death. The goal of the current investigation was to ascertain the incidence of different ovarian tumor histological and morphological variants in a tertiary healthcare center in southern India.

Methods: The study, which took place in a tertiary healthcare facility in Chennai, involved 89 ovary specimens that were obtained over the course of 18 months (from August 2021 to December 2022) from patients in the obstetrics and gynecology department. The specimens underwent both histological and critical gross examination. Standard H&E-stained paraffin slices were observed. After being organized on proforma, the histology results were examined.

Results: A total of 89 patients, ranging in age from 16 to 90, were enrolled in the study. The majority of patients (30.3%) were in the age range of 31 to 40 years. The majority of ovarian tumors were benign, accounting for 58 (65.2%) of the total, while malignant tumors accounted for 25 (28.1%). The most prevalent type of tumors, according to the World Health Organization (WHO) classification, were surface epithelial tumors (76.12%), followed by germ cell tumors (18.46%). In the current investigation, one case of metastatic tumors to the ovaries was also identified. Serous cystadenoma 29 (32.6%) was found to be the most prevalent subtype among the many known subtypes of ovarian tumors, followed by papillary serous carcinoma 14 (15.7%).

Conclusions: Compared to malignant or borderline tumors, benign ovarian tumors are more common. Surface epithelial tumors are the most prevalent histological subtype of ovarian cancers, followed by germ cell tumors. It's critical to distinguish between benign and malignant tumors in order to ensure appropriate treatment and healing. Future research of this kind with a larger sample size is advised.

Metrics

Metrics Loading ...

References

Chandanwale SS, Jadhav R, Rao R, Naragude P, Bhamnikar S, Ansari JN. Clinicopathologic study of malignant ovarian tumors: A study of fifty cases. Med J Dr Patil Univ. 2017;10:430.

Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, et al. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2). Gynecol Oncol. 2017;144(2):405-13.

Yousif HM, Mohammed RA, Missawi HM, Elsawaf ZM, Albasri AM. Histopathological patterns of primary malignant ovarian neoplasms in different age groups in Almadinah Almunawwarah region, KSA. J Taibah Univ Med Sci. 2018;14(1):73-8.

Narula R. Overview of benign and malignant tumors of the female genital tract. J Appl Pharm Sci. 2013;3:13-27.

Jha R, Karki S. Histological pattern of ovarian tumors and their age distribution. Nepal Med Coll J NMCJ. 2008;10:81-5.

Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM. Global ovarian cancer health disparities. Gynecol Oncol. 2013;129(1):258-64.

Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I, et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Ann Oncol. 2019;30(5):672-705.

Ugai T, Kelemen LE, Mizuno M, Ong JS, Webb PM, Chenevix-Trench G, et al. Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium. Cancer Sci. 2018;109(2):435-45.

Mabuchi S, Sugiyama T, Kimura T. Clear cell carcinoma of the ovary: Molecular insights and future therapeutic perspectives. J Gynecol Oncol. 2016;27:31.

Sharma DS, Kulkarni CV, Yadav A, Rajput M. Clinical and histopathological correlation of ovarian neoplasms: A retrospective study. J Med Sci Clin Res. 2019;7:1-6.

Vanusha F, Kirubamani NH. Clinical correlation of ovarian mass with ultrasound findings and histopathology report. Int J Reprod Contracept Obstet Gynecol. 2017;6:5230-4.

Patil RK, Bhandari BJ, Kittur SK, Haravi RM, Aruna S, Jadhav MN. Histomorphological study of ovarian tumors: At a tertiary care centre. Ann Pathol Lab Med. 2017;4(6):A638-45.

Kuladeepa AV, Muddegowda PH, Lingegowda JB, Doddikoppad MM, Basavaraja PK, Hiremath SS. Histomorphological study of 134 primary ovarian tumors. Adv Lab Med Int. 2011;1(4):69-82.

Pal T, Permuth-Wey J, Kumar A, Sellers TA. Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology. Clin Cancer Res. 2008;14(21):6847-54.

Kumar V, Kaur N, Das T, Bal MS. Correlation of various clinical findings and chief complaints with Histopathological pattern of Endometrial Biopsies; A Study of 300 cases. J Med Health Sci. 2014;3(3):2014.

Bhagyalakshmi A, Sreelekha A, Sridevi S, Chandralekha J, Parvathi G, Venkatalakshmi A. Prospective study of histopathological patterns of ovarian tumours in a tertiary care centre. Int J Res. 2014;2:448-56.

Willis S, Villalobos VM, Gevaert O, Abramovitz M, Williams C, Sikic BI, et al. Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis. PLoS One. 2016;17:0149183.

Garg N, Anand A, Annigeri C. Study of histomorphological spectrum of ovarian tumours. Int J Med Health Res. 2017;3:12-20.

Kayastha S. Study of ovarian tumours in Nepal Medical College Teaching Hospital. Nepal Med Coll J. 2009;11:200-2.

Ahmad Z, Kayani N, Hasan SH, Muzaffar S, Gill MS. Histological pattern of ovarian neoplasma. J Pak Med Assoc. 2000;50(12):416.

Modepalli N, Venugopal SB. Clinicopathological Study of Surface Epithelial Tumours of the Ovary: An Institutional Study. J Clin Diagn Res. 2016;10:01-4.

Pilli GS, Suneeta KP, Dhaded AV, Yenni VV. Ovarian tumours: a study of 282 cases. J Indian Med Assoc. 2002;100(7):420-3.

Akakpo PK, Derkyi-Kwarteng L, Gyasi RK, Quayson SE, Naporo S, Anim JT. A pathological and clinical study of 706 primary tumours of the ovary in the largest tertiary hospital in Ghana. BMC Women Health. 2017;17:1-6.